Main > PHARMA. > Saw Palmetto

Product USA. PU

PATENT ASSIGNEE'S COUNTRY USA
UPDATE 03.00
PATENT ASSIGNEE Pharmaprint
University of Southern California
PATENT CLAIMS Method for determn standard bioactivity for saw palmetto extract
- Obtaining sample of alc. saw palmetto extract
- Measuring total bioactivity by determn an IC50 in androgen
receptor binding inhibition assay
- Measuring total fatty acid content of an aliquot of whole
sample
- Fractionating sample & collecting individual fractions
- Measuring fatty acid content of each fraction
- Identifying the fractions contg Et linoleate & Et laurate
- Measuring bioactivity for each of the fractions identified in
step above
- Calculating % activity of each of the fractions for which an
drogen receptor binding inhibition has been assayed com
pared to total bioactivity of sample, wherein the MW &
amount of the individual fatty acids identified are incorpora
ted into the calculating &
- Determining that if the total bioactivity of the sample is >
selected minimum standard amount, & if the total % activity
pf the Et linoleate & Et laurate fractions is > 25% of total
bioactivity, then the saw palmetto extract has standard
bioactivity
PATENT PHOTOCOPY Available on request

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back